Corvus Prescribed drugs Proclaims New Information Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Most cancers By Investing.com
BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Prescribed drugs, Inc.…
INmune Bio stories progress in prostate most cancers trial By Investing.com
BOCA RATON, Fla. - INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology…
